Literature DB >> 7671942

Sleep apnoea in babies born after in vitro fertilization.

H Audiens1, E Denayer, N Ahlenajafie, E Troch, M Bonduelle, J Ramet, Y Vandenplas.   

Abstract

UNLABELLED: Babies born after in vitro fertilisation (IVF) are increasing in number, and, although these babies are considered as very precious, no data are available regarding their risk for sudden infant death or apnoea. To evaluate the respiratory maturity of IVF babies, we evaluated the incidence of apnoea during an 8-h polysomnography in 50 consecutively presented IVF babies and in a group of 50 unselected naturally conceived babies. All infants were in good health and matched for term (born > 38 weeks of gestation), birth weight, sex and age at the time of investigation (6-11 weeks post term, median 8.0). There were 24 twins in the IVF and 6 twins in the control group. The incidence of obstructive and isolated central apnoea was comparable in the IVF and control group. However, IVF babies had significantly more periodic breathing episodes than control babies (median 2.30 (range 0-15.30) in IVF, and 1.02 (range 0-11.2) in control babies; P < 0.01). This difference was not related to the higher number of twins in the IVF group. Single IVF babies had significantly more short central apnoeas (5-10 s) than IVF twins (5-10 s) (mean 38.80 +/- 18.63 and 22.33 +/- 13.35; P < 0.001). This difference between single and twin babies was not found in the control group.
CONCLUSION: IVF babies have more periodic breathing episodes indicating an immature respiratory pattern than normally conceived babies.

Entities:  

Mesh:

Year:  1995        PMID: 7671942     DOI: 10.1007/bf02029354

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Sequential 22-hour profiles of breathing patterns and heart rate in 110 full-term infants during their first 6 months of life.

Authors:  J M Richards; J R Alexander; E A Shinebourne; M de Swiet; A J Wilson; D P Southall
Journal:  Pediatrics       Date:  1984-11       Impact factor: 7.124

2.  Sudden infant death syndrome in twins.

Authors:  S Beal
Journal:  Pediatrics       Date:  1989-12       Impact factor: 7.124

3.  Mixed and obstructive sleep apnea and near miss for sudden infant death syndrome: 2. Comparison of near miss and normal control infants by age.

Authors:  C Guilleminault; R Ariagno; R Korobkin; L Nagel; R Baldwin; S Coons; M Owen
Journal:  Pediatrics       Date:  1979-12       Impact factor: 7.124

4.  Patterns of gastroesophageal reflux (GER) in patients with apparent life-threatening events.

Authors:  L J Newman; J Russe; M S Glassman; S Berezin; M S Halata; M S Medow; A J Dozor; S M Schwarz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-02       Impact factor: 2.839

5.  Gastroesophageal reflux in infants: relation to apnea.

Authors:  J K Walsh; M K Farrell; W J Keenan; M Lucas; M Kramer
Journal:  J Pediatr       Date:  1981-08       Impact factor: 4.406

Review 6.  Sudden infant death syndrome: 1987 perspective.

Authors:  C E Hunt; R T Brouillette
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

7.  Periodic breathing in infants with near-miss sudden infant death syndrome.

Authors:  D H Kelly; D C Shannon
Journal:  Pediatrics       Date:  1979-03       Impact factor: 7.124

8.  Effects of obstructive sleep apneas on transcutaneous oxygen pressure in control infants, siblings of sudden infant death syndrome victims, and near miss infants: comparison with the effects of central sleep apneas.

Authors:  A Kahn; D Blum; P Waterschoot; E Engelman; P Smets
Journal:  Pediatrics       Date:  1982-12       Impact factor: 7.124

9.  Gastroesophageal reflux associated with respiratory abnormalities during sleep.

Authors:  L Sacré; Y Vandenplas
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-07       Impact factor: 2.839

10.  Pneumograms in infants who subsequently died of sudden infant death syndrome.

Authors:  D H Kelly; H Golub; D Carley; D C Shannon
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.